Latest drug prices and trends for NDC 65862-0967

Subscribe to access the full database, or Try for Free
Drug Name	NDC	Price/Unit ($)	Unit	Date
ESZOPICLONE 1 MG TABLET	65862-0967-30	0.13331	EACH	2025-03-19
ESZOPICLONE 1 MG TABLET	65862-0967-01	0.13331	EACH	2025-03-19
ESZOPICLONE 1 MG TABLET	65862-0967-30	0.12412	EACH	2025-02-19
ESZOPICLONE 1 MG TABLET	65862-0967-01	0.12412	EACH	2025-02-19
ESZOPICLONE 1 MG TABLET	65862-0967-30	0.11946	EACH	2025-01-22
>Drug Name	>NDC	>Price/Unit ($)	>Unit	>Date

Subscribe to access the full database, or Try for Free

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table
>Drug Name	>Vendor	>NDC	>Count	>Price ($)	>Price/Unit ($)	>Dates	>Price Type

The pharmaceutical industry is a dynamic and complex sector, constantly evolving to meet the changing needs of patients and healthcare providers. In this article, we'll dive deep into the market analysis and price projections for a specific drug identified by the National Drug Code (NDC) 65862-0967, which corresponds to Eszopiclone manufactured by Aurobindo Pharma Limited.

Understanding NDC 65862-0967: Eszopiclone

Eszopiclone, marketed under the brand name Lunesta, is a non-benzodiazepine hypnotic agent used for the treatment of insomnia[1]. As a generic version produced by Aurobindo Pharma Limited, this medication plays a significant role in the sleep aid market.

The Role of Aurobindo Pharma Limited

Aurobindo Pharma Limited is a major player in the global pharmaceutical industry, known for its extensive portfolio of generic and specialty drugs[2]. The company's ability to produce high-quality generic drugs at competitive prices gives it a strong market position.

Market Demand for Eszopiclone

The demand for sleep aids like Eszopiclone has been steadily increasing, driven by factors such as:

Rising prevalence of sleep disorders
Increasing stress levels in modern society
Growing awareness about the importance of quality sleep

According to recent studies, the global sleep aid market is expected to reach $101.9 billion by 2026, growing at a CAGR of 6.8% from 2021 to 2026[3].

Competitive Landscape

The generic drug market for sleep aids is highly competitive. Several manufacturers produce generic versions of Eszopiclone, which impacts pricing and market share. Key competitors include:

Teva Pharmaceuticals
Mylan N.V.
Dr. Reddy's Laboratories

This competitive environment tends to keep prices relatively stable or even drive them down over time.

Pricing Trends for NDC 65862-0967

While specific pricing data for NDC 65862-0967 is not publicly available, we can infer trends based on similar generic drugs and market conditions. Generic drug prices generally tend to decrease over time due to competition and market saturation.

"Generic drug prices are generally stable or decreasing due to competition and regulatory pressures."[2]

Factors Influencing Price Projections

Several factors will influence the future pricing of Eszopiclone (NDC 65862-0967):

1. Raw Material Costs

Fluctuations in the cost of active pharmaceutical ingredients (APIs) and other raw materials can impact the overall production cost and, consequently, the price of the drug.

2. Regulatory Changes

Any changes in FDA regulations or listing requirements can affect the availability and pricing of the drug. Compliance with regulatory requirements is crucial for maintaining market presence[1].

3. Market Competition

The presence of multiple generic versions of Eszopiclone in the market creates price pressure. As more competitors enter the market, prices tend to decrease.

4. Healthcare Policies

Changes in healthcare policies, such as those related to Medicare Part D, can significantly impact drug pricing. For instance, the implementation of the Inflation Reduction Act aims to lower prescription drug costs for seniors[8].

5. Global Economic Factors

Economic conditions, including inflation rates and currency fluctuations, can influence production costs and, consequently, drug prices.

Short-Term Price Projections

In the short term (1-2 years), prices for generic drugs like Eszopiclone are likely to remain stable or see slight decreases. This projection is based on:

Ongoing market competition
Regulatory pressures to keep drug prices affordable
Potential impacts of the Inflation Reduction Act

Long-Term Price Projections

Looking further ahead (3-5 years), several factors could influence the pricing of NDC 65862-0967:

1. Technological Advancements

Improvements in manufacturing processes could potentially lower production costs, leading to price reductions.

2. Market Saturation

As the market for Eszopiclone matures, prices may stabilize or decrease further due to increased competition and reduced profit margins.

3. Potential New Entrants

The entry of new manufacturers into the market could intensify competition and drive prices down.

4. Shifts in Treatment Paradigms

Changes in insomnia treatment guidelines or the introduction of new sleep aid medications could impact the demand for Eszopiclone, affecting its pricing.

Impact of the Inflation Reduction Act

The Inflation Reduction Act, signed into law in 2022, aims to lower prescription drug costs for seniors. While Eszopiclone is not currently on the list of drugs selected for Medicare price negotiations, the act's broader impacts on the pharmaceutical market could indirectly affect its pricing[8].

Aurobindo Pharma's Market Strategy

Aurobindo Pharma's strategy for NDC 65862-0967 likely focuses on:

Maintaining competitive pricing
Ensuring consistent quality and supply
Expanding market share through strategic partnerships and distribution channels

The Role of AI in Drug Discovery and Pricing

The increasing adoption of AI-based tools in drug discovery and development could potentially impact future pricing strategies. AI can help optimize manufacturing processes, potentially reducing production costs[3].

Global Pharmaceutical Market Trends

The U.S. pharmaceutical market is projected to grow from $846.72 billion in 2022 to $1.28 trillion by 2030, representing a Compound Annual Growth Rate (CAGR) of 5.36%[3]. This growth could influence pricing strategies for generic drugs like Eszopiclone.

Potential Challenges and Opportunities

Challenges:

Increasing competition in the generic drug market
Potential raw material shortages
Regulatory compliance costs

Opportunities:

Expansion into new geographic markets
Development of improved formulations or delivery methods
Strategic partnerships with healthcare providers or insurers

Consumer Impact

For consumers, the pricing trends of Eszopiclone have significant implications:

Stable or decreasing prices could improve access to sleep aid medications
Potential savings for patients, especially those paying out-of-pocket
Increased competition may lead to improved quality and more options

Future of Sleep Aid Market

The sleep aid market is expected to continue growing, driven by factors such as:

Aging population
Increasing prevalence of sleep disorders
Growing awareness of the importance of sleep health

This growth could potentially support stable pricing for drugs like Eszopiclone.

Key Takeaways

NDC 65862-0967 corresponds to Eszopiclone, a generic sleep aid manufactured by Aurobindo Pharma Limited.
The sleep aid market is growing, with projections reaching $101.9 billion by 2026.
Short-term price projections suggest stability or slight decreases due to market competition and regulatory pressures.
Long-term pricing will be influenced by factors such as technological advancements, market saturation, and potential new entrants.
The Inflation Reduction Act and other healthcare policies may indirectly impact pricing.
AI adoption in drug discovery and development could potentially influence future pricing strategies.
Aurobindo Pharma's market strategy likely focuses on competitive pricing, quality assurance, and market expansion.
Consumers may benefit from stable or decreasing prices, potentially improving access to sleep aid medications.

FAQs

What is the significance of NDC 65862-0967? NDC 65862-0967 is the National Drug Code for Eszopiclone, a generic sleep aid manufactured by Aurobindo Pharma Limited.
How does the Inflation Reduction Act affect drug pricing? The Inflation Reduction Act aims to lower prescription drug costs for seniors through measures such as allowing Medicare to negotiate prices for certain drugs. While not directly impacting all drugs, it could have broader effects on the pharmaceutical market.
What factors contribute to the pricing of generic drugs like Eszopiclone? Factors include raw material costs, regulatory requirements, market competition, healthcare policies, and global economic conditions.
How is AI impacting the pharmaceutical industry? AI is being increasingly adopted in drug discovery and development processes, potentially optimizing manufacturing and reducing production costs.
What are the projected growth trends for the U.S. pharmaceutical market? The U.S. pharmaceutical market is projected to grow from $846.72 billion in 2022 to $1.28 trillion by 2030, with a CAGR of 5.36%.

Sources cited:

Drug Price Trends for NDC 65862-0967

Average Pharmacy Cost for 65862-0967

Best Wholesale Price for NDC 65862-0967

Market Analysis and Price Projections for NDC 65862-0967: Eszopiclone by Aurobindo Pharma Limited